
PERCH at EUROGIN 2025: To Improve HPV Vaccination Coverage Across Europe
PERCH at EUROGIN 2025: To Improve HPV Vaccination Coverage Across Europe At the EUROGIN 2025 conference in Porto on March 18th, Assist. Prof. Urška Ivanuš,
PERCH at EUROGIN 2025: To Improve HPV Vaccination Coverage Across Europe At the EUROGIN 2025 conference in Porto on March 18th, Assist. Prof. Urška Ivanuš,
PERCH General Assembly Highlights Achievements and Future Plans On December 9, 2024, the PERCH consortium gathered for its General Assembly in Paris, bringing together in-person
As part of Work Package 4 (WP4) Integration and Sustainability and Work Package 2 (WP2) Communication and Dissemination, the PERCH initiative aims to improve the
The UICC World Cancer Congress recently hosted a digital session titled “Cervical Cancer Elimination: Local and European Experiences for Global Learnings.” This session addressed the
Human Papilloma infections prevention. The european Joint Action partnERschip to contrast HPV (PERCH) and e-lerning for the health professionals – Papillomavirus (HPV) infection is
On June 21, the Council of the European Union took an important step in the fight against cancer by adopting a Council Recommendation on vaccine-preventable
Work Package 7 (WP) of the PERCH project is dedicated to improving the communication skills of healthcare professionals regarding the human papillomavirus (HPV) vaccine. By
Work Package 6 (WP6) deals with “Improving knowledge and awareness to increase vaccine uptake in target communities”. Its general objective is to improve knowledge and
Recently an editorial article “Linkage of individual-patient data confirms protection of prophylactic human papillomavirus vaccination against invasive cervical cancer,” was published in the “JNCI: Journal
At this year’s EUROGIN Congress in Stockholm, the project was presented by experts involved in the project on Saturday, March 16th in the scientific sessions,
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not re!ect those of the European Union or European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them.